Clinical Trial Update: Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial compared calcium dobesilate with cabergoline to prevent ovarian hyperstimulation syndrome in infertility treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• CABERGOLINE (CABERGOLINE)
• Calcium dobesilate (calcium dobesilate)

Snippet

Sponsor: Benha University | Conditions: Infertility | Phase 2, Phase 3 | Status: COMPLETED